Vita Life Sciences provided earnings guidance for the full year ending 31 December 2022. For the year, the company expects sales of $64.0 million to $65.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 AUD | -2.27% | -11.52% | +20.79% |
1st Jan change | Capi. | |
---|---|---|
+20.79% | 77.76M | |
+25.61% | 660B | |
+22.68% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+13.06% | 219B | |
-9.61% | 196B | |
+6.40% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- VLS Stock
- News Vita Life Sciences Limited
- Vita Life Sciences Provides Earnings Guidance for the Full Year Ending 31 December 2022